NYSE:PFE
Lpath Granted Two Additional U.S. Patents Related to iSONEP and ASONEP Drug Programs
SAN DIEGO, CA–(Marketwire – Oct 5, 2011) – Lpath, Inc. (OTCBB: LPTN), the industry leader in lipidomics-based antibody therapeutics, received official notification from the U.S. Patent and Trademark Office (USPTO) that Lpath has been issued two fur… […]
